AIP
IDXX icon

Ahrens Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Ahrens Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.5K Buy
+5
New +$2.39K ﹤0.01% 859
2022
Q3 		– Sell
-5
Closed -$2K – 512
2022
Q2 		$2K Hold
5
– – ﹤0.01% 875
2022
Q1 		$3K Hold
5
– – ﹤0.01% 912
2021
Q4 		$3K Buy
+5
New +$3.14K ﹤0.01% 931

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ahrens Investment Partners's IDXX Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Idexx Laboratories (IDXX) in Q1 2023: 5 shares worth $2.5K. The stake represents ﹤0.01% of the portfolio and ranks #859 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in IDXX as recently as Q2 2022.

Ahrens Investment Partners first reported a position in IDXX in Q4 2021 and has held it in 4 quarters since. The position peaked at $3K in Q1 2022. 1,055 funds tracked by Wall St. Rank hold IDXX as of Q1 2023.

  • Ahrens Investment Partners held 5 shares of Idexx Laboratories worth $2.5K as of Q1 2023.
  • Idexx Laboratories was a new Ahrens Investment Partners position in Q1 2023.
  • Idexx Laboratories made up ﹤0.01% of Ahrens Investment Partners's portfolio in Q1 2023, its #859 holding.
  • Ahrens Investment Partners first reported a position in Idexx Laboratories in Q4 2021 and has held it in 4 quarters since.
  • Ahrens Investment Partners's Idexx Laboratories position peaked at $3K in Q1 2022.
  • 1,055 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.